These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 31242985

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Combined preoperative denosumab and adjuvant microwave ablation for high-risk giant cell tumor of bone: a retrospective study in a single center.
    Zheng C, Xu G, Zhou X, Qiu J, Lan T, Zhang S, Li W.
    J Orthop Surg Res; 2024 Aug 17; 19(1):488. PubMed ID: 39154187
    [Abstract] [Full Text] [Related]

  • 25. Giant cell tumours of bone treated with denosumab: histological, immunohistochemical and H3F3A mutation analyses.
    Kato I, Furuya M, Matsuo K, Kawabata Y, Tanaka R, Ohashi K.
    Histopathology; 2018 May 17; 72(6):914-922. PubMed ID: 29206281
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Denosumab: a new treatment option for giant cell tumor of bone.
    Lewin J, Thomas D.
    Drugs Today (Barc); 2013 Nov 17; 49(11):693-700. PubMed ID: 24308016
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Histone H3.3 mutation in giant cell tumor of bone: an update in pathology.
    Yamamoto H, Ishihara S, Toda Y, Oda Y.
    Med Mol Morphol; 2020 Mar 17; 53(1):1-6. PubMed ID: 31748824
    [Abstract] [Full Text] [Related]

  • 30. Denosumab treatment of inoperable or locally advanced giant cell tumor of bone - Multicenter analysis outside clinical trial.
    Rutkowski P, Gaston L, Borkowska A, Stacchiotti S, Gelderblom H, Baldi GG, Palmerini E, Casali P, Gronchi A, Parry M, Campanacci DA, Scoccianti G, Wagrodzki M, Ferrari S, Dijkstra S, Pieńkowski A, Grimer R.
    Eur J Surg Oncol; 2018 Sep 17; 44(9):1384-1390. PubMed ID: 29650420
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 study.
    Urakawa H, Yonemoto T, Matsumoto S, Takagi T, Asanuma K, Watanuki M, Takemoto A, Naka N, Matsumoto Y, Kawai A, Kunisada T, Kubo T, Emori M, Hiraga H, Hatano H, Tsukushi S, Nishida Y, Akisue T, Morii T, Takahashi M, Nagano A, Yoshikawa H, Sato K, Kawano M, Hiraoka K, Tanaka K, Iwamoto Y, Ozaki T.
    World J Surg Oncol; 2018 Aug 08; 16(1):160. PubMed ID: 30089488
    [Abstract] [Full Text] [Related]

  • 35. The clinical approach toward giant cell tumor of bone.
    van der Heijden L, Dijkstra PD, van de Sande MA, Kroep JR, Nout RA, van Rijswijk CS, Bovée JV, Hogendoorn PC, Gelderblom H.
    Oncologist; 2014 May 08; 19(5):550-61. PubMed ID: 24718514
    [Abstract] [Full Text] [Related]

  • 36. Does Denosumab Change the Giant Cell Tumor Treatment Strategy? Lessons Learned From Early Experience.
    Agarwal MG, Gundavda MK, Gupta R, Reddy R.
    Clin Orthop Relat Res; 2018 Sep 08; 476(9):1773-1782. PubMed ID: 30794215
    [Abstract] [Full Text] [Related]

  • 37. Giant cell tumor of bone: current treatment options.
    Skubitz KM.
    Curr Treat Options Oncol; 2014 Sep 08; 15(3):507-18. PubMed ID: 24788576
    [Abstract] [Full Text] [Related]

  • 38. Neoadjuvant and Adjuvant Treatment with Denosumab in Aggressive Giant-cell Tumor of Bone in the Proximal Fibula: a Case Report.
    Marinova VV, Slavchev SA, Patrikov KD, Tsenova PM, Georgiev GP.
    Folia Med (Plovdiv); 2018 Dec 01; 60(4):637-640. PubMed ID: 31188771
    [Abstract] [Full Text] [Related]

  • 39. Denosumab for the treatment of giant cell tumor of the bone.
    Brodowicz T, Hemetsberger M, Windhager R.
    Future Oncol; 2015 Dec 01; 11(13):1881-94. PubMed ID: 26161925
    [Abstract] [Full Text] [Related]

  • 40. Denosumab versus zoledronic acid in cases of surgically unsalvageable giant cell tumor of bone: A randomized clinical trial.
    Yue J, Sun W, Li S.
    J Bone Oncol; 2022 Aug 01; 35():100441. PubMed ID: 35800292
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.